Switzerland-based Limula today announced a raise of $6.8mn (€6.2mn) to further develop its technology, which aims to automate cell therapy manufacturing. Gene and cell therapies have emerged as a ...

Cellares unveiled Cell Q Thursday, the first automated quality control (QC) workcell for cell therapy manufacturing. According to the company, Cell Q complements its Cell Shuttle Platform by ...

Creative 3D Technologies (C3DT) announced today that its EVO platform has been recognized with two CES® 2026 Innovation Awards. Creative 3D was first publicly shown at CES years ago. It’s both ...

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

We live in an age of incredible technological advancement, yet we face critical shortages and high costs in many essential areas. To solve the challenge, I believe we need to build more. A lot more.

Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...